Xenon Pharmaceuticals to Present at the Stifel 2023 CNS Days
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a biopharmaceutical company focused on neurology, will present at the virtual Stifel 2023 CNS Days on March 28-29, 2023.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a biopharmaceutical company focused on neurology, will present at the virtual Stifel 2023 CNS Days on March 28-29, 2023. The presentation will feature Ian Mortimer, President and CEO, and Sherry Aulin, CFO, on March 28 at 1:00 PM Eastern Time (10:00 AM Pacific Time). A live webcast will be available and can be pre-registered for via a provided link. Xenon is dedicated to developing innovative therapies for neurological disorders, particularly epilepsy. For further information, visit www.xenon-pharma.com.
Details
News Market Reaction – XENE
The recorded move for XENE in the trading session of this news was +1.31%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURNABY, British Columbia, March 22, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the virtual Stifel 2023 CNS Days taking place March 28-29, 2023.
| Company Fireside Chat Presentation Details: | |
| Date: | Tuesday, March 28, 2023 |
| Time: | 1:00 pm Eastern Time (10:00 am Pacific Time) |
| Presenters: | Ian Mortimer, President and CEO |
| Sherry Aulin, CFO | |
| Webcast: | Link to pre-register for the webcast can be found here. |
A live webcast of the company presentation will be available on the “Investors” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.
Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.